PRE-NEED
Detect what is likely to be needed next from bounded signals. Prediction can create a proposal, never an implicit mandate.
Machine Action Infrastructure
VALO sits between machine intent and real-world consequence — governing what may happen, proving what happened, and improving the economics of verified outcomes.
Systems execute. Evidence proves.
VALO is not a catalogue of unrelated AI projects. We develop bounded capabilities for the operational chain around machine work. A workload uses only the capabilities it needs.
Detect what is likely to be needed next from bounded signals. Prediction can create a proposal, never an implicit mandate.
Let new work benefit from verified prior experience without carrying the full history forward.
Research whether long-running machine work can preserve goal continuity under controlled tests.
Determine whether this exact consequence-bearing action may execute now under current authority, purpose and constraints.
Bind risk and underwriting-relevant evidence to consequential work where the domain requires it.
Improve existing machine workloads and establish whether the gain in cost, quality, latency, throughput or resources survives verification and production.
Preserve evidence of what was authorized, executed and observed so outcomes can be inspected and replayed.
Only governed, admitted evidence may affect future operative state. Persistence alone is not authority.
The stack around this boundary may change. Models, agent runtimes, clouds, hardware and external effect providers may be replaced. The Handlingsrett boundary remains. Prediction is not mandate. Risk and admissibility do not grant authority. Economic value does not grant authority.
Machine Action Infrastructure is the category. The Execution Layer is its technical placement. The commercial entry remains narrow: one workload, one consequence or one measurable economic problem.
VALO publishes bounded results and material limitations where appropriate. Product communication describes capability, measured outcome and evidence — proprietary mechanisms remain internal.